Table 3

Multivariable odds of major adverse cardiovascular events (MACE) and in-hospital death for patients prelockdown and postlockdown who underwent primary percutaneous coronary intervention for ST-elevation myocardial infarction

GroupComparison of postlockdown versus prelockdown
No imputationsImputed dataset
Adjusted OR (95% CI)*P valueAdjusted OR (95% CI)†P value
Overall
 MACE0.71 (0.39 to 1.32)0.280.78 (0.50 to 1.24)0.29
 In-hospital death0.87 (0.45 to 1.68)0.670.94 (0.58 to 1.52)0.80
Direct from community
 MACE0.66 (0.33 to 1.30)0.230.63 (0.36 to 1.10)0.10
 In-hospital death0.77 (0.37 to 1.63)0.500.74 (0.41 to 1.33)0.31
Transfer
 MACE0.88 (0.16 to 5.02)0.891.39 (0.50 to 3.86)0.52
 In-hospital death1.18 (0.20 to 7.10)0.861.86 (0.66 to 5.28)0.24
  • *Adjusted for age, sex, hypertension, hypercholesterolaemia, diabetes mellitus, renal disease, previous myocardial infarction, previous stroke, previous percutaneous coronary intervention, previous coronary artery bypass graft, peripheral vascular disease, valvular heart disease, radial access, multivessel disease, vessel of intervention, medications, glycoprotein IIb/IIIa inhibitor use, imaging, rotational atherectomy, intra-aortic balloon pump, extracorporeal membrane oxygenation/impella, cardiogenic shock, inotropes, number of stents, flow, thrombectomy, symptom-to-hospital time, door-to-balloon time, out-of-hours symptoms and out-of-hours percutaneous coronary intervention.

  • †Adjusted for all variables in * and left ventricular function, ethnicity and smokers.